These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 1423819)

  • 1. The role of fibrin in tumor metastasis.
    Costantini V; Zacharski LR
    Cancer Metastasis Rev; 1992 Nov; 11(3-4):283-90. PubMed ID: 1423819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinolytic mechanisms in tumor growth and spreading.
    Südhoff T; Schneider W
    Clin Investig; 1992 Aug; 70(8):631-6. PubMed ID: 1392438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The significance of fibrin/fibrinogen for growth and metastasis of malignant tumors (author's transl)].
    Heyes H; Glück D
    Klin Wochenschr; 1977 Nov; 55(22):1079-87. PubMed ID: 145507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal regulation of coagulation/fibrinolysis in small cell carcinoma of the lung.
    Wojtukiewicz MZ; Zacharski LR; Memoli VA; Kisiel W; Kudryk BJ; Rousseau SM; Stump DC
    Cancer; 1990 Feb; 65(3):481-5. PubMed ID: 2153429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coexisting macrophage-associated fibrin formation and tumor cell urokinase in squamous cell and adenocarcinoma of the lung tissues.
    Ornstein DL; Zacharski LR; Memoli VA; Kisiel W; Kudryk BJ; Hunt J; Rousseau SM; Stump DC
    Cancer; 1991 Sep; 68(5):1061-7. PubMed ID: 1913476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrinogen and tumor cell metastasis.
    Palumbo JS; Degen JL
    Haemostasis; 2001; 31 Suppl 1():11-5. PubMed ID: 11990465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemostasis and malignancy.
    Francis JL; Biggerstaff J; Amirkhosravi A
    Semin Thromb Hemost; 1998; 24(2):93-109. PubMed ID: 9579631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrin polymerization and its regulatory role in hemostasis.
    Mosesson MW
    J Lab Clin Med; 1990 Jul; 116(1):8-17. PubMed ID: 2198321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant melanoma. Interaction with coagulation and fibrinolysis pathways in situ.
    Wojtukiewicz MZ; Zacharski LR; Memoli VA; Kisiel W; Kudryk BJ; Rousseau SM; Stump DC
    Am J Clin Pathol; 1990 Apr; 93(4):516-21. PubMed ID: 1690950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The significance of the fibrin/fibrinogen degradation product in serum of carcinoma patients with hematogenous metastasis.
    Imaoka S; Sasaki Y; Iwanaga T; Terasawa T
    Cancer; 1986 Oct; 58(7):1488-92. PubMed ID: 3742466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered plasma fibrin clot properties and fibrinolysis in patients with multiple myeloma.
    Undas A; Zubkiewicz-Usnarska L; Helbig G; Woszczyk D; Kozińska J; Dmoszyńska A; Podolak-Dawidziak M; Kuliczkowski K
    Eur J Clin Invest; 2014 Jun; 44(6):557-66. PubMed ID: 24738991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Functional and diagnostic significance of A-, Bbeta 1-42 and Bbeta 15-42 peptide fragments of fibrin(ogen)].
    Makogonenko EM; Lugovskoĭ EV; Kolesnik LA; Kudinov SA
    Ukr Biokhim Zh (1978); 1992; 64(4):78-82. PubMed ID: 1448878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrin as a component of the tumor stroma: origins and biological significance.
    Dvorak HF; Senger DR; Dvorak AM
    Cancer Metastasis Rev; 1983; 2(1):41-73. PubMed ID: 6193869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrinogen-fibrin conversion and inhibition of fibrinolysis.
    Stemberger A; Blümel G
    Thorac Cardiovasc Surg; 1982 Aug; 30(4):209-14. PubMed ID: 6182629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [From fibrinogen to fibrin and its dissolution].
    Juhan-Vague I; Hans M
    Bull Acad Natl Med; 2003; 187(1):69-82; discussion 83-4. PubMed ID: 14556455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tumor metastasis and the fibrinolytic system].
    Yamamura M; Yamamoto M
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1246-54. PubMed ID: 2730023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid dissociation of platelet-rich fibrin clots in vitro by a combination of plasminogen activators and antiplatelet agents.
    Lam SC; Dieter JP; Strebel LC; Taylor TM; Muscolino G; Feinberg H; Le Breton GC
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1371-8. PubMed ID: 1762085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes of the coagulation and fibrinolysis system in malignancy: their possible impact on future diagnostic and therapeutic procedures.
    Korte W
    Clin Chem Lab Med; 2000 Aug; 38(8):679-92. PubMed ID: 11071061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrinogen deposition without thrombin generation in primary human breast cancer tissue.
    Costantini V; Zacharski LR; Memoli VA; Kisiel W; Kudryk BJ; Rousseau SM
    Cancer Res; 1991 Jan; 51(1):349-53. PubMed ID: 1670992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical trials with anticoagulant and antiplatelet therapies.
    Zacharski LR; Meehan KR; Algarra SM; Calvo FA
    Cancer Metastasis Rev; 1992 Nov; 11(3-4):421-31. PubMed ID: 1423826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.